Industries > Pharma > Medical Device Leader Series: Top Pre-Filled Injection Device Manufacturers 2018-2028

Medical Device Leader Series: Top Pre-Filled Injection Device Manufacturers 2018-2028

Profiles, R&D and Revenue Forecasting for Leading Syringe, Injector and Component Producers and Contract Filling Services

PUBLISHED: 13 November 2018
PAGES: 213
PRODUCT CODE: PHA0340
SUBMARKET: Medical Devices

Clear
WOOCS 2.2.1
DOWNLOAD SAMPLE
SKU: PHA0340 Categories: , Tags: , , , , ,

The Pre-Filled Device Manufacturing market is estimated to reach $7.5bn in 2022, growing at a CAGR of 10.5% from 2017 to 2022.

The majority of revenues for pre-filled syringe manufacturers, including component manufacturers and pen injector/autoinjector manufacturers, came from developed markets. In 2017, the US was the largest market for pre-filled injection devices, accounting for 39.9% of global revenues.

How this 213-page report delivers:

• Provides an overview and revenue forecasts of the global pre-filled injectable devices market from 2018 to 2028

• Profiles of selected leading companies in the pre-filled injection device manufacturing:
• Leading pre-filled syringe manufacturers
• Leading pre-filled injectable component manufacturers
• Leading pen injector and autoinjector manufacturers
• Leading pre-filled injectable devices contract manufacturers

• Companies profiled in this report:
• Aptar Stelmi
• Becton, Dickinson, & Co (BD)
• Bespak Injectables
• Boehringer Ingelheim
• Catalent
• Dätwyler Holding
• Gerresheimer
• Haselmeier
• Laboratorios Farmacéuticos ROVI
• Nemera
• Nipro
• Ompi
• Owen Mumford
• Roselabs Group.
• Schott
• SHL Group
• Tip-top
• Vetter Pharma
• Weigao Group Pharmaceutical Packaging Products Company
• West Pharmaceutical Services.
• Ypsomed

Top Pre-Filled Injection Device Manufacturers 2018-2028

• Information provided for the selected leading companies, when available:
• Overview of the company
• Historical Revenues
• Revenue forecasts from 2018-2028
• A SWOT analysis
• A competitive analysis
• Products & Services
• Business Developments: Expansion, new products, mergers, acquisitions, collaborations.

• This report also discusses the key trends in the pre-filled injection device manufacturing market.

101 charts unavailable elsewhere

Visiongain’s study is intended for anyone requiring commercial analyses for the pre-filled injection device manufacturing market. You find data, trends and predictions.

Buy our report today Top Pre-Filled Injection Device Manufacturers 2018-2028: Profiles, R&D and Revenue Forecasting for Leading Syringe, Injector and Component Producers and Contract Filling Services.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Medical Device Leader Series: Top Pre-Filled Injection Device Manufacturers 2018-2028


Download sample pages

Complete the form below to download your free sample pages for Medical Device Leader Series: Top Pre-Filled Injection Device Manufacturers 2018-2028


Latest Pharma news

“Global oxygen therapy market will grow at a CAGR over 10.0% by 2030”, says Visiongain

Visiongain’s new report the Oxygen Therapy Market Report 2020-2030: Forecasts by Product (Oxygen Source Equipment, Oxygen Delivery Devices, Static, Dynamic), By Application, By End-use) plus analysis of leading companies indicates that the global oxygen therapy market will grow at a CAGR over 10.0% by 2030. The main drivers of the industry were increased incidences of chronic respiratory diseases coupled with …

23 January 2020

READ

“Global Ovarian Cancer Drugs market will grow at a CAGR over 20.0% by 2030”, says Visiongain

Visiongain’s new report the Ovarian Cancer Drugs Market Report 2020-2030: Forecasts by Therapeutic Class(PARP, PD-L1, Angiogenesis Inhibitors) plus analysis of leading companies indicates that the global Ovarian Cancer Drugs market will grow at a CAGR over 20.0% by 2030. One of the main factors in accelerating market growth is the rising incidence of ovarian cancer due to growing geriatric population …

23 January 2020

READ

“Global Empty Capsules Market set to grow to $2.8bn by 2025” says new Visiongain report

The non-gelatin capsules segment is estimated to grow at the highest CAGR during the forecast period.

23 January 2020

READ

“Global ophthalmic packaging market will grow at a CAGR over 5% by 2030”, says Visiongain

Visiongain’s new report the Ophthalmic Packaging Market Report 2020-2030: Forecasts by Dose (single dose, multiple dose), by Type (OTC and prescription) by Material (Glass, plastic, and others) plus analysis of leading companies indicates that the global ophthalmic packaging market will grow at a CAGR over 5% by 2030. The main factors driving demand are the increasing prevalence of eye disorders, …

23 January 2020

READ

Categories

Category